APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lancets

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Selected research

Market Structure

Global Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchLancets Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lancets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lancets Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Lancets Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Homecare Lancets is the main type, with a share about 80%. Glucose Tests is the main application, which holds a share about 70%.

Read the full market overview

This report provides an overview of the global Lancets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lancets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lancets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lancets market size, projected growth trends, production technologies, key applications, and end-use industries.

Lancets Segment by Company

Roche

Lifescan

BD

Bayer

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

Infopia

AgaMatrix

Smiths Medical

Sarstedt

SANNUO

Yicheng

Yuwell

Greiner Bio One

Edan

Narang Medical

Lancets Segment by Type

Safety Lancets

Homecare Lancets

Lancets Segment by Application

Cholesterol Tests

Glucose Tests

Others

Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lancets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lancets Industry Trends Table 2. Lancets Industry Drivers Table 3. Lancets Industry Opportunities and Challenges Table 4. Lancets Industry Restraints Table 5. Global Lancets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lancets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lancets Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Lancets Sales Market Share by Manufacturers Table 9. Global Lancets Average Sales Price (US$/K Units) of Manufacturers (2021-2026) Table 10. Global Lancets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lancets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lancets Manufacturers, Product Type & Application Table 13. Global Lancets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lancets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Safety Lancets Table 17. Major Manufacturers of Homecare Lancets Table 18. Global Lancets Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Lancets Sales by Type (2021-2026) & (M Units) Table 20. Global Lancets Sales by Type (2027-2032) & (M Units) Table 21. Global Lancets Sales Market Share by Type (2021-2026) Table 22. Global Lancets Sales Market Share by Type (2027-2032) Table 23. Global Lancets Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Lancets Revenue by Type (2021-2026) & (M Units) Table 25. Global Lancets Revenue by Type (2027-2032) & (M Units) Table 26. Global Lancets Revenue Market Share by Type (2021-2026) Table 27. Global Lancets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cholesterol Tests Table 29. Major Manufacturers of Glucose Tests Table 30. Major Manufacturers of Others Table 31. Global Lancets Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Lancets Sales by Application (2021-2026) & (M Units) Table 33. Global Lancets Sales by Application (2027-2032) & (M Units) Table 34. Global Lancets Sales Market Share by Application (2021-2026) Table 35. Global Lancets Sales Market Share by Application (2027-2032) Table 36. Global Lancets Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Lancets Revenue by Application (2021-2026) & (M Units) Table 38. Global Lancets Revenue by Application (2027-2032) & (M Units) Table 39. Global Lancets Revenue Market Share by Application (2021-2026) Table 40. Global Lancets Revenue Market Share by Application (2027-2032) Table 41. Global Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Lancets Sales by Region (2021-2026) & (M Units) Table 43. Global Lancets Sales Market Share by Region (2021-2026) Table 44. Global Lancets Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Lancets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Lancets Sales by Country (2021-2026) & (M Units) Table 48. North America Lancets Sales by Country (2027-2032) & (M Units) Table 49. Europe Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Lancets Sales by Country (2021-2026) & (M Units) Table 51. Europe Lancets Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Lancets Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Lancets Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Lancets Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Lancets Sales by Country (2027-2032) & (M Units) Table 58. Global Lancets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lancets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lancets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lancets Revenue Market Share by Region (2021-2026) Table 62. Global Lancets Revenue Market Share by Region (2027-2032) Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Roche Lancets Product Portfolio Table 67. Roche Recent Development Table 68. Lifescan Company Information Table 69. Lifescan Business Overview Table 70. Lifescan Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lifescan Lancets Product Portfolio Table 72. Lifescan Recent Development Table 73. BD Company Information Table 74. BD Business Overview Table 75. BD Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BD Lancets Product Portfolio Table 77. BD Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bayer Lancets Product Portfolio Table 82. Bayer Recent Development Table 83. Abbott Company Information Table 84. Abbott Business Overview Table 85. Abbott Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Abbott Lancets Product Portfolio Table 87. Abbott Recent Development Table 88. B. Braun Company Information Table 89. B. Braun Business Overview Table 90. B. Braun Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. B. Braun Lancets Product Portfolio Table 92. B. Braun Recent Development Table 93. ARKRAY Company Information Table 94. ARKRAY Business Overview Table 95. ARKRAY Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ARKRAY Lancets Product Portfolio Table 97. ARKRAY Recent Development Table 98. Terumo Company Information Table 99. Terumo Business Overview Table 100. Terumo Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Terumo Lancets Product Portfolio Table 102. Terumo Recent Development Table 103. I-SENS Company Information Table 104. I-SENS Business Overview Table 105. I-SENS Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. I-SENS Lancets Product Portfolio Table 107. I-SENS Recent Development Table 108. Nipro Company Information Table 109. Nipro Business Overview Table 110. Nipro Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nipro Lancets Product Portfolio Table 112. Nipro Recent Development Table 113. Omron Company Information Table 114. Omron Business Overview Table 115. Omron Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Omron Lancets Product Portfolio Table 117. Omron Recent Development Table 118. Infopia Company Information Table 119. Infopia Business Overview Table 120. Infopia Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Infopia Lancets Product Portfolio Table 122. Infopia Recent Development Table 123. AgaMatrix Company Information Table 124. AgaMatrix Business Overview Table 125. AgaMatrix Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AgaMatrix Lancets Product Portfolio Table 127. AgaMatrix Recent Development Table 128. Smiths Medical Company Information Table 129. Smiths Medical Business Overview Table 130. Smiths Medical Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Smiths Medical Lancets Product Portfolio Table 132. Smiths Medical Recent Development Table 133. Sarstedt Company Information Table 134. Sarstedt Business Overview Table 135. Sarstedt Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sarstedt Lancets Product Portfolio Table 137. Sarstedt Recent Development Table 138. SANNUO Company Information Table 139. SANNUO Business Overview Table 140. SANNUO Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. SANNUO Lancets Product Portfolio Table 142. SANNUO Recent Development Table 143. Yicheng Company Information Table 144. Yicheng Business Overview Table 145. Yicheng Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Yicheng Lancets Product Portfolio Table 147. Yicheng Recent Development Table 148. Yuwell Company Information Table 149. Yuwell Business Overview Table 150. Yuwell Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Yuwell Lancets Product Portfolio Table 152. Yuwell Recent Development Table 153. Greiner Bio One Company Information Table 154. Greiner Bio One Business Overview Table 155. Greiner Bio One Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Greiner Bio One Lancets Product Portfolio Table 157. Greiner Bio One Recent Development Table 158. Edan Company Information Table 159. Edan Business Overview Table 160. Edan Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Edan Lancets Product Portfolio Table 162. Edan Recent Development Table 163. Narang Medical Company Information Table 164. Narang Medical Business Overview Table 165. Narang Medical Lancets Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Narang Medical Lancets Product Portfolio Table 167. Narang Medical Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Lancets Distributors List Table 171. Lancets Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Lancets Product Image Figure 2. Global Lancets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lancets Market Size (2021-2032) & (US$ Million) Figure 4. Global Lancets Sales (2021-2032) & (M Units) Figure 5. Global Lancets Average Price (US$/K Units) & (2021-2032) Figure 6. Global Top 5 and 10 Lancets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Safety Lancets Image Figure 9. Homecare Lancets Image Figure 10. Global Lancets Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Lancets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lancets Sales Market Share by Type (2021-2032) Figure 13. Global Lancets Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Lancets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lancets Revenue Market Share by Type (2021-2032) Figure 16. Cholesterol Tests Image Figure 17. Glucose Tests Image Figure 18. Others Image Figure 19. Global Lancets Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Lancets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lancets Sales Market Share by Application (2021-2032) Figure 22. Global Lancets Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Lancets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lancets Revenue Market Share by Application (2021-2032) Figure 25. North America Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Lancets Sales Market Share by Country (2021-2032) Figure 27. U.S. Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Lancets Sales Market Share by Country (2021-2032) Figure 32. Germany Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Lancets Sales Market Share by Country (2021-2032) Figure 39. China Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Lancets Sales Market Share by Country (2021-2032) Figure 47. Brazil Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Lancets Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Lancets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lancets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lancets Revenue (2021-2032) & (US$ Million) Figure 58. North America Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lancets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lancets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lancets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lancets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lancets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lancets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets
  • Homecare Lancets
Applications
  • Cholesterol Tests
  • Glucose Tests
  • Others
Companies covered
  • Roche
  • Lifescan
  • BD
  • Bayer
  • Abbott
  • B. Braun
  • ARKRAY
  • Terumo
  • I-SENS
  • Nipro
  • Omron
  • Infopia
  • AgaMatrix
  • Smiths Medical
  • Sarstedt
  • SANNUO
  • Yicheng
  • Yuwell
  • Greiner Bio One
  • Edan
  • Narang Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lancets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lancets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lancets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lancets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lancets Market Dynamics
  1. 2.1 Lancets Industry Trends
  2. 2.2 Lancets Industry Drivers
  3. 2.3 Lancets Industry Opportunities and Challenges
  4. 2.4 Lancets Industry Restraints
3 Lancets Market by Manufacturers
  1. 3.1 Global Lancets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lancets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lancets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lancets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lancets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lancets Manufacturers, Product Type & Application
  7. 3.7 Global Lancets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lancets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lancets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lancets Tier 1, Tier 2, and Tier 3
4 Lancets Market by Type
  1. 4.1 Lancets Type Introduction
  2. 4.1.1 Safety Lancets
  3. 4.1.2 Homecare Lancets
  4. 4.2 Global Lancets Sales by Type
  5. 4.2.1 Global Lancets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lancets Sales by Type (2021-2032)
  7. 4.2.3 Global Lancets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lancets Revenue by Type
  9. 4.3.1 Global Lancets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lancets Revenue by Type (2021-2032)
  11. 4.3.3 Global Lancets Revenue Market Share by Type (2021-2032)
5 Lancets Market by Application
  1. 5.1 Lancets Application Introduction
  2. 5.1.1 Cholesterol Tests
  3. 5.1.2 Glucose Tests
  4. 5.1.3 Others
  5. 5.2 Global Lancets Sales by Application
  6. 5.2.1 Global Lancets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lancets Sales by Application (2021-2032)
  8. 5.2.3 Global Lancets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lancets Revenue by Application
  10. 5.3.1 Global Lancets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lancets Revenue by Application (2021-2032)
  12. 5.3.3 Global Lancets Revenue Market Share by Application (2021-2032)
6 Global Lancets Sales by Region
  1. 6.1 Global Lancets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lancets Sales by Region (2021-2032)
  3. 6.2.1 Global Lancets Sales by Region (2021-2026)
  4. 6.2.2 Global Lancets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lancets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lancets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lancets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lancets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lancets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lancets Revenue by Region
  1. 7.1 Global Lancets Revenue by Region
  2. 7.1.1 Global Lancets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lancets Revenue by Region (2021-2026)
  4. 7.1.3 Global Lancets Revenue by Region (2027-2032)
  5. 7.1.4 Global Lancets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lancets Revenue (2021-2032)
  8. 7.2.2 North America Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lancets Revenue (2021-2032)
  11. 7.3.2 Europe Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lancets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lancets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lancets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Lancets Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Lifescan
  8. 8.2.1 Lifescan Company Information
  9. 8.2.2 Lifescan Business Overview
  10. 8.2.3 Lifescan Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lifescan Lancets Product Portfolio
  12. 8.2.5 Lifescan Recent Developments
  13. 8.3 BD
  14. 8.3.1 BD Company Information
  15. 8.3.2 BD Business Overview
  16. 8.3.3 BD Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BD Lancets Product Portfolio
  18. 8.3.5 BD Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Lancets Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Abbott
  26. 8.5.1 Abbott Company Information
  27. 8.5.2 Abbott Business Overview
  28. 8.5.3 Abbott Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Lancets Product Portfolio
  30. 8.5.5 Abbott Recent Developments
  31. 8.6 B. Braun
  32. 8.6.1 B. Braun Company Information
  33. 8.6.2 B. Braun Business Overview
  34. 8.6.3 B. Braun Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Lancets Product Portfolio
  36. 8.6.5 B. Braun Recent Developments
  37. 8.7 ARKRAY
  38. 8.7.1 ARKRAY Company Information
  39. 8.7.2 ARKRAY Business Overview
  40. 8.7.3 ARKRAY Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ARKRAY Lancets Product Portfolio
  42. 8.7.5 ARKRAY Recent Developments
  43. 8.8 Terumo
  44. 8.8.1 Terumo Company Information
  45. 8.8.2 Terumo Business Overview
  46. 8.8.3 Terumo Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Terumo Lancets Product Portfolio
  48. 8.8.5 Terumo Recent Developments
  49. 8.9 I-SENS
  50. 8.9.1 I-SENS Company Information
  51. 8.9.2 I-SENS Business Overview
  52. 8.9.3 I-SENS Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 I-SENS Lancets Product Portfolio
  54. 8.9.5 I-SENS Recent Developments
  55. 8.10 Nipro
  56. 8.10.1 Nipro Company Information
  57. 8.10.2 Nipro Business Overview
  58. 8.10.3 Nipro Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nipro Lancets Product Portfolio
  60. 8.10.5 Nipro Recent Developments
  61. 8.11 Omron
  62. 8.11.1 Omron Company Information
  63. 8.11.2 Omron Business Overview
  64. 8.11.3 Omron Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Omron Lancets Product Portfolio
  66. 8.11.5 Omron Recent Developments
  67. 8.12 Infopia
  68. 8.12.1 Infopia Company Information
  69. 8.12.2 Infopia Business Overview
  70. 8.12.3 Infopia Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Infopia Lancets Product Portfolio
  72. 8.12.5 Infopia Recent Developments
  73. 8.13 AgaMatrix
  74. 8.13.1 AgaMatrix Company Information
  75. 8.13.2 AgaMatrix Business Overview
  76. 8.13.3 AgaMatrix Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AgaMatrix Lancets Product Portfolio
  78. 8.13.5 AgaMatrix Recent Developments
  79. 8.14 Smiths Medical
  80. 8.14.1 Smiths Medical Company Information
  81. 8.14.2 Smiths Medical Business Overview
  82. 8.14.3 Smiths Medical Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Smiths Medical Lancets Product Portfolio
  84. 8.14.5 Smiths Medical Recent Developments
  85. 8.15 Sarstedt
  86. 8.15.1 Sarstedt Company Information
  87. 8.15.2 Sarstedt Business Overview
  88. 8.15.3 Sarstedt Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sarstedt Lancets Product Portfolio
  90. 8.15.5 Sarstedt Recent Developments
  91. 8.16 SANNUO
  92. 8.16.1 SANNUO Company Information
  93. 8.16.2 SANNUO Business Overview
  94. 8.16.3 SANNUO Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 SANNUO Lancets Product Portfolio
  96. 8.16.5 SANNUO Recent Developments
  97. 8.17 Yicheng
  98. 8.17.1 Yicheng Company Information
  99. 8.17.2 Yicheng Business Overview
  100. 8.17.3 Yicheng Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Yicheng Lancets Product Portfolio
  102. 8.17.5 Yicheng Recent Developments
  103. 8.18 Yuwell
  104. 8.18.1 Yuwell Company Information
  105. 8.18.2 Yuwell Business Overview
  106. 8.18.3 Yuwell Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Yuwell Lancets Product Portfolio
  108. 8.18.5 Yuwell Recent Developments
  109. 8.19 Greiner Bio One
  110. 8.19.1 Greiner Bio One Company Information
  111. 8.19.2 Greiner Bio One Business Overview
  112. 8.19.3 Greiner Bio One Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Greiner Bio One Lancets Product Portfolio
  114. 8.19.5 Greiner Bio One Recent Developments
  115. 8.20 Edan
  116. 8.20.1 Edan Company Information
  117. 8.20.2 Edan Business Overview
  118. 8.20.3 Edan Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Edan Lancets Product Portfolio
  120. 8.20.5 Edan Recent Developments
  121. 8.21 Narang Medical
  122. 8.21.1 Narang Medical Company Information
  123. 8.21.2 Narang Medical Business Overview
  124. 8.21.3 Narang Medical Lancets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Narang Medical Lancets Product Portfolio
  126. 8.21.5 Narang Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lancets Value Chain Analysis
  2. 9.1.1 Lancets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lancets Production Mode & Process
  6. 9.2 Lancets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lancets Distributors
  9. 9.2.3 Lancets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst